Categories
Torrent Pharmaceuticals Limited — Updates, 22-05-2026: Press Release
22-05-2026 · 04:52 pm
Torrent Pharma reported strong Q4 FY26 consolidated results: Revenue up 42% to ₹4,197 Cr, Operating EBITDA up 41% to ₹1,356 Cr. Net Profit ₹364 Cr. The Board announced a final dividend of ₹9/share and seeks shareholder approval for raising up to ₹5,000 Cr via QIP. JB Pharma acquisition integration drives growth.
No comments yet. Be the first to comment!